Vancouver Convention Centre | Vancouver, BC, Canada | 26-28 February 2012
BioPartnering North America is for Serious Deal Makers
Annually attracting 800+ decision-makers and industry leaders from over 30 countries, BPN offers a unique opportunity to access a global network of potential partners.
For more information, please click here
Applications are now being accepted for the 2012 International BioGENEius Challenge, the premier biotechnology high school research competition!
What is the BioGENEius Challenge?
The BioGENEius Challenge is the most prestigious high school (Grades 9 to 12) science competition in the world for original research in biotechnology. Each student conducts an individual research project and is currently enrolled in biology or science-related courses in any public, private or home school within the United States.
How can I become a winner?
First, you must apply to the appropriate At-Large or Local BioGENEius Challenge. After applying for the appropriate BioGENEius Challenge you may be selected to compete and/or present at the Local BioGENEius Challenge provided in your area. Up to 2 students are selected from each Local BioGENEius Challenge and 15 students from the At-Large Challenge. The selected winners of both the Local and At-Large BioGENEius Challenges will present their research poster and oral presentations at the U.S. National BioGENEius Challenge, which will be held in June 17, 2012 in Boston, Massachusetts
For specific details and information regarding the BioGENEius Challenge please visit www.biotechinstitute.org/node/1447.
At Large BioGENEius Challenge
The At-Large BioGENEius is a competition available to students who are not in areas from which the local competitions draw. These students will apply directly to the Biotechnology Institute through the online application process. The Biotechnology Institute will host a virtual competition in which a panel of judges will convene and review each completed research project submission. The judges will then select 15 student delegates. The selected 15 students will join the winners of each Local BioGENEius Challenge(s) to present their research poster and oral presentations and advance to the U.S. National BioGENEius Challenge. The U.S. National BioGENEius Challenge will be held June 17, 2012 in Boston, MA.
Source: Inside Indiana Business
Former Pfizer Plant Gets New Life
A California-based pharmaceutical company has announced plans to redevelop the former Pfizer facility in Terre Haute. NantWorks LLC wants to invest $85.5 million to open a pharmaceutical manufacturing plant and create up to 234 jobs by 2016.
Read More
From Inside Indiana Business:
Franciscan St. Francis Health, St. Vincent Health and Community Health Network say they have been selected to provide cancer tissue for a historic project. The National Institutes of Health says its Cancer Genome Atlas Project will analyze thousands of tumors from each cancer type studied in the program. Read More Principal Investigator at Community Health Network and St. Vincent Dr. Jeff Mossler says this isn’t the first time the Indianapolis hospitals have collaborated on a cancer project.
Listen
The FDA has released draft guidance outlining the process for reviewing low-risk medical devices seeking approval under the 510(k) program. The guidance is up for comment through April 26. The Hill/Healthwatch blog
Indiana at Center of Boom in Health Care and Life Sciences Industry
NEW YORK (Jan. 3, 2012) – The national law firm of Epstein Becker Green (EBG) today announced that it is expanding its presence in Indiana by opening an office in Indianapolis to better serve its growing health care and life sciences client base. Indiana is home to some of the biggest names in the health care and life sciences fields and, according to the Wall Street Journal (WSJ), is at the center of the booming life
sciences industry. The WSJ stated that Indiana has added 8,800 jobs in life sciences in recent years and is home to approximately 825 medical device companies, drug manufacturers, and research labs.
For several years, EBG has been building a presence in Indiana with health care and life sciences attorneys on the ground, including Leah Kendall and Bradley Merrill Thompson, both Members of the Firm in its Health Care and Life Sciences practice. A lifelong resident of Indiana, Ms. Kendall graduated summa cum laude from Butler University and summa cum laude (first in her class) from the Indiana University School
of Law in Bloomington. She has been practicing food and drug law in Indiana ever since. Mr. Thompson began practicing food and drug law with an emphasis on medical device companies 26 years ago in Indiana. He has represented nearly every major drug and medical device manufacturer in Indiana, and many of the smaller and midsized companies. Mr. Thompson founded the Indiana Medical Device Manufacturers Council in 1991 and was one of the founders, and the first executive director, of the Indiana Health Industry Forum in 1993. In addition, Thompson taught food and drug law at the Indiana University Law School in Indianapolis during the early 1990s.
“EBG would like to applaud the many civic leaders in Indiana who have set the stage for this growth in the Indiana life sciences industry. The work of organizations such as the Indiana Health Industry Forum has been and will continue to be critical to the continued expansion of the life sciences industry in the Hoosier state,” said Ms. Kendall, who will work out of the Firm’s Indianapolis and Washington, D.C., offices.
During the last six years, while continuing to live in Indiana, Ms. Kendall and Mr. Thompson have worked out of EBG’s office in D.C., traveling throughout the United States and internationally to counsel companies on compliance with FDA requirements.
Contact:
Marichelli Hughes
Public Relations Manager
Epstein Becker Green
(202) 861-1872
mhughes@egblaw.com
The SBIR & STTR Programs have finally been reauthorized! This 6 year reauthorization, included in the National Defense Authorization Act, will allow venture capital backed companies to compete for up to 25% of SBIR grants from NIH, DOE and NSF and 15% at other agencies.
Stericycle ExpertRECALL has recently launched an industry resource: the ExpertRECALL Index, a comprehensive summary of cumulative recall data from various regulatory agencies. The data, providing specific information on medical devices and pharmaceutical products, can be found at http://www.expertrecall.com/recallindex/ or on the IHIF website under “Industry Data“.
Thursday, December 8, 2012 – Indiana Senator Dan Coats introduced S. 1972: A bill to amend the Food and Drug Administration’s mission. The FDA Mission Reform Act would require the FDA to establish a predictable, consistent and transparent regulatory environment.
For more information on the bill, please visit Sen. Coats’ website:
During the JP Morgan HealthCare Conference
Wednesday, January 11, 2012, The Nikko Hotel, San Francisco
8:00 – 10:00:
Non-Dilutive Funding Forecast
8:00 – 9:00: Breakfast and Networking
9:00 – 10:00: “NIH/DOD 2012 Forecast – Current RFAs & RFPs”
Mr. Ram May-Ron, Managing Partner, FreeMind Group
Merav Geva, Ph.D, Chief Analyst & Director of Professional Services, FreeMind Group
10:15 – 1:45:
Round Table Discussions:
Merav Geva, Ph.D, Chief Analyst & Director of Professional Services, FreeMind Group
10:15 AM – Translational Research
11:00 AM – Devices and Technology Development (Platform Technology)
11:45 AM – Industry-Academia partnerships
1:00 PM – DoD and related agencies
2:30 – 3:30:
“Private Foundation Funding” Panel
Moderator – Mr. Ram May-Ron, Managing Partner, FreeMind Group
Speakers –
Michael J. Fox Foundation
Juvenile Diabetes Research Foundation International (JDRF)
American Heart Association
This event is FREE of charge.
To schedule 1X1 meeting with the FreeMind team please contact Hannah Rosencweig at (617)648 .0340 ext. 220 hannah@freemindconsultants.com
Click here for registration:
http://events.constantcontact.com/register/event?llr=cfjxi7bab&oeidk=a07e5f5m35m13c2ff64
